Literature DB >> 3514656

Serospecificity of a cloned protease-resistant Treponema pallidum--specific antigen expressed in Escherichia coli.

S R Coates, P J Sheridan, D S Hansen, W J Laird, H A Erlich.   

Abstract

We evaluated the serological reactivity of a protease-resistant antigen designated 4D which was encoded by Treponema pallidum DNA and was expressed in Escherichia coli from recombinant plasmid pAW329. This 19,000-molecular-weight antigen was purified in its native, non-protease-treated form from E. coli sonic extracts by molecular sieving and ion-exchange chromatography. Antibody binding to antigen 4D was detected by a radioimmunoassay. Antigen 4D-specific antibody was detected in 95% of the sera in a Centers for Disease Control syphilis serum panel. It was also detected in 55% of 121 primary syphilis patients, whereas syphilis antibody was detected in 83% of the sera by a fluorescent treponemal antibody absorption test and in 88% of the sera by a T. pallidum microhemagglutination test. In tests of 118 normal sera, less than 3% demonstrated antibody to antigen 4D; these results are similar to microhemagglutination and fluorescent treponemal antibody absorption test results. Rabbit antisera against Treponema phagedenis, Treponema refringens, Treponema denticola, and Treponema vincentii did not react with antigen 4D.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514656      PMCID: PMC268674          DOI: 10.1128/jcm.23.3.460-464.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  AN IMPROVED FTA TEST FOR SYPHILIS, THE ABSORPTION PROCEDURE (FTA-ABS).

Authors:  E F HUNTER; W E DEACON; P E MEYER
Journal:  Public Health Rep       Date:  1964-05       Impact factor: 2.792

Review 2.  The impact of new cloning techniques on the diagnosis and treatment of infectious diseases.

Authors:  N C Engleberg; B I Eisenstein
Journal:  N Engl J Med       Date:  1984-10-04       Impact factor: 91.245

3.  Expression of Treponema pallidum antigens in Escherichia coli.

Authors:  A M Walfield; P A Hanff; M A Lovett
Journal:  Science       Date:  1982-04-30       Impact factor: 47.728

4.  Reactivity of microhemagglutination, fluorescent treponemal antibody absorption, and venereal disease research laboratory tests in primary syphilis.

Authors:  J D Dyckman; S Storms; T W Huber
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

5.  Humoral immune response in human syphilis to polypeptides of Treponema pallidum.

Authors:  P A Hanff; T E Fehniger; J N Miller; M A Lovett
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis.

Authors:  M Moskophidis; F Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Cultivation of virulent Treponema pallidum in tissue culture.

Authors:  A H Fieldsteel; D L Cox; R A Moeckli
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Identification and preliminary characterization of Treponema pallidum protein antigens expressed in Escherichia coli.

Authors:  L V Stamm; T C Kerner; V A Bankaitis; P J Bassford
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Assessing B cell diversification by antigen receptor and precursor cell analysis.

Authors:  N R Klinman; A R Pickard; N H Sigal; P J Gearhart; E S Metcalf; S K Pierce
Journal:  Ann Immunol (Paris)       Date:  1976 Jun-Jul

10.  Antigenic complexity of Treponema pallidum: antigenicity and surface localization of major polypeptides.

Authors:  S J Norris; S Sell
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

View more
  1 in total

1.  Expression of antigens from chromosomal and linear plasmid DNA of Borrelia coriaceae.

Authors:  G C Perng; R B LeFebvre
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.